NCT00081809
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
- Locations
-
- M.D. Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
1,630 public trials
214 recruiting studies
Lymphoma, Non-Hodgkin trial results
NCT00571493
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
Completed
A Combination of Acalabrutinib With R-CHOP for Patient Diffuse Large B-cell Lymphoma (DLBCL)
NCT03571308
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Southampton University Hospitals NHS Tust Southampton, Hampshire, United Kingdom
- St James's University Hospital Leeds, United Kingdom
- University College London Hospitals London, United Kingdom
- The Christie NHS Foundation Trust Manchester, United Kingdom
NCT00550615
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- University of Nebraska Medical Center, Internal Medicine Section of Oncology/Hematology Omaha, Nebraska, United States
NCT02661035
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, B-cell Lymphoma, +59 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
NCT01739309
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pessac, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Homburg, Germany
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kassel, Germany
NCT00574730
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Unversity of Nebraska Medical Center Omaha, Nebraska, United States
NCT01696461
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +31 more
- Locations
-
- H. Lee Moffitt Cancer Center Tampa, Florida, United States
- Emory University Atlanta, Georgia, United States
- University of Chicago Chicago, Illinois, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT01951885
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +41 more
- Locations
-
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00004197
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States